N-(tert-butoxycarbonyl)piperidine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 7010304 |
| SCHEMBL ID | 13445 |
| MeSH ID | M0425009 |
| Synonym |
|---|
| n-boc-piperidine, 98% |
| AKOS005145952 |
| A9632 |
| tert-butyl piperidine-1-carboxylate |
| n-(tert-butoxycarbonyl)piperidine |
| n-boc-piperidine |
| 75844-69-8 |
| 1-boc-piperidine |
| n-boc-tetrahydropyridine |
| FT-0607419 |
| LF-0527 |
| AM20100740 |
| CS-M1633 |
| tert-butyl 1-piperidinecarboxylate |
| SCHEMBL13445 |
| boc-piperidine |
| piperidine-1-carboxylic acid tert-butyl ester |
| tert-butyl-1-piperidinecarboxylate |
| n-(tert-butoxycarbonyl)piperadine |
| piperidine-1-carboxylic acid tert butyl ester |
| 1,1-dimethylethyl piperidine-1-carboxylate |
| n-tert-butoxycarbonyl piperidine |
| RQCNHUCCQJMSRG-UHFFFAOYSA-N |
| n-boc piperidine |
| piperidinecarboxylic acid tert-butyl ester |
| tert-butyl piperadine-1-carboxylate |
| 1-(tert-butoxycarbonyl)piperidine |
| tert-butyl 1-piperadinecarboxylate |
| tert-butyloxycarbonylpiperidine |
| n-boc tetrahydropyridine |
| 1-piperidinecarboxylic acid, 1,1-dimethylethyl ester |
| DTXSID30426618 |
| B4625 |
| mfcd02093935 |
| J-524813 |
| SB42937 |
| EN300-139030 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||